Scientists mapped where drugs bind inside the body, cell by cell, to better understand benefits and side effects.

A new study maps the biological influences on thousands of plasma proteins, revealing potential disease biomarkers and drug targets, providing hope for more precise, personalized treatments. Study: ...

Researchers created a new kind of cancer drug that can grab a mutant protein while also carrying a second hit against the ...

Discover how mapping plasma proteins to diseases in 53,000 adults is transforming diagnostics, advancing treatments, and paving the way for personalized healthcare solutions. Study: Atlas of the ...

Located at the cellular interface, membrane proteins play critical regulatory roles in the signaling between a cell and its interacting environment, making them popular and ideal drug targets.

Light chain amyloidosis is not cancer, but cancer drugs are this rare disease’s standard of care. The patient need for new treatment options has sparked R&D efforts at biotech and big pharmaceutical ...

A generalizable ML framework predicts protein interactions with ligand-stabilized gold nanoclusters, supporting faster design of bioimaging, sensing and drug delivery materials.

Various approaches to such protein redesign have drawbacks. Traditional methods include time-consuming trial and error efforts, and many models in the emerging field ...